Abstract

There has been a fundamental shift in the relevance and implementation of health preference research. In this themed section, Marsh et al¹ show that health preference evidence currently has a wide range of applications to support reimbursement and pricing decisions in the European Union with pilot projects in the focus on choice-based methods and multi-criteria decision analysis.